Home » Topics » Regulatory » Patents

Patents
RSS

(+)-Enantiomer of known compound acts as potent, selective NMDA receptor antagonist

Oct. 29, 1998

Ionotropic glutamate receptor ligands described by Lilly for CNS disorders

Oct. 28, 1998

New serotonergic agents in development at ADIR for CNS disorders

Oct. 27, 1998

Shiseido claims pyrrolidines for gastric and peptic ulcers

Oct. 27, 1998

Yamanouchi discloses 5-HT2C receptor agonists with high potency and selectivity

Oct. 27, 1998

Korean research institute develops new NMDA receptor antagonists

Oct. 27, 1998

Agents for schizophrenia from Yoshitomi typified by Y-36074

Oct. 27, 1998

Preparation and pharmaceutical formulations of nimesulide choline salt claimed by Dompe

Oct. 27, 1998

Safe and effective therapeutics for neuropathic pain in early development at Roche

Oct. 26, 1998

Benzamides with antiulcer, antisecretory and anti-H. pylori effects discovered at Shiseido

Oct. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...